Houlihan Lokey · 2 days ago
2027 Investment Banking Summer Financial Analyst (Class of 2028) – Washington DC Industrials
Houlihan Lokey is a global investment bank specializing in mergers and acquisitions, capital solutions, and financial advisory. The Summer Financial Analyst role provides exposure to various investment banking services and responsibilities, including research and analysis of financial statements and market conditions.
BankingFinanceFinancial Services
Responsibilities
In Corporate Finance, Summer Financial Analysts may work on a variety of transactions that provide exposure to various investment banking services and client industries
These services include mergers and acquisitions, private placements of debt and equity, refinancings, and leveraged buyouts
Throughout the summer, you will work with a highly talented and dedicated staff of professionals who will give you broad exposure to the many different issues and concerns affecting businesses today
You will research and analyze financial statements, general and industry-specific economic conditions and developments, acquisitions and divestitures, and various investment attributes of publicly traded and private securities companies
The environment at Houlihan Lokey is collaborative and entrepreneurial and rewards Summer Financial Analysts with substantial responsibility and interaction with senior-level professionals
Qualification
Required
Currently pursuing a Bachelor's and/or Master's Degree with a graduation date between December 2027 and June 2028
Possess basic knowledge of and a keen interest in finance
Excellent verbal and written communication skills
Strong work ethic and leadership skills
Preferred
A fundamental understanding of valuation theory, methodologies, and applications
Strong analytical and computer skills (Excel)
Ability to work cooperatively with all levels of staff
Company
Houlihan Lokey
Houlihan Lokey is an investment bank specializing in mergers and acquisitions, capital solutions, and financial restructuring.
Funding
Current Stage
Public CompanyTotal Funding
unknown2015-08-12IPO
2005-10-31Acquired
Recent News
Secondaries Investor
2025-12-18
2025-12-01
Company data provided by crunchbase